Inhibition of the enzyme histonedeacetylase (HDAC) is emerging as a novel approach to the treatment of cancer. A series of novelsulfonamidederivatives were synthesized and evaluated for their ability to inhibit human HDAC. Compounds were identified which are potent enzyme inhibitors, with IC50 values in the low nanomolar range against enzyme obtained from HeLa cell extracts, and with antiproliferative
作者:Tannya R. Ibarra-Rivera、Rocio Gámez-Montaño、Luis D. Miranda
DOI:10.1039/b705397e
日期:——
An efficient xanthate-based method for the preparation of azaspirocyclic cyclohexadienones via an ipso oxidative radical cyclization of p-oxygenated N-benzylacetamides and N-phenetylacetamide is described.
The present invention relates to 3,4-dihydroisoquinolinium salt derivatives. More specifically, the present invention relates to 3,4-dihydroisoquinolinium salt derivatives of the following chemical formula (I).